A newer medication, Tirzepatide, also addresses type 2 diabetes and obesity but offers a dual-action approach by combining GLP-1 receptor agonism with GIP activation
Monitor urine color as a hydration indicatorpale yellow suggests adequate hydration, while dark yellow or amber indicates the need for more fluids Increase fluid intake during episodes of nausea, vomiting, or diarrhea to compensate for losses and prevent dehydration Sip water throughout the day rather than consuming large volumes at once, which may worsen nausea Consider oral rehydration solutions (available over-the-counter) if experiencing persistent diarrhea or vomiting, as these replace both fluids and electrolytes Moderate caffeine intake , as it can have mild diuretic effects, though regular caffeine consumers typically develop tolerance to this effect Patients experiencing persistent nausea may find it challenging to maintain fluid intake
M., da Silva, A
It is important to note that oral semaglutide is not currently FDA-approved for weight management as a primary indication, whereas injectable semaglutide has specific approval for chronic weight management at the 2.4 mg dose
Active eating disorder or history of eating disorder (bulimia, anorexia, etc.) 5
